EUVIMEDEUVIMED entdecken
Multizentrische Studie

Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort

Chien-Chien Cheng, Pang-Shuo Huang, Jien-Jiun Chen, Fu-Chun Chiu, Sheng-Nan Chang, Yi-Chih Wang, Cho-Kai Wu, Juey-Jen Hwang, Chia-Ti Tsai

Heart Rhythm · 2024

DOI: 10.1016/j.hrthm.2024.02.048 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Heart Rhythm, 2024. Verfasst von Chien-Chien Cheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Taiwan University College of Medicine, Taipei, Taiwan. Hauptthemen laut MEDLINE: Stroke Volume, Heart Failure, Atrial Fibrillation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Congestive heart failure (CHF) as a risk of stroke in patients with atrial fibrillation (AF) mainly referred to patients with left ventricular systolic dysfunction. Whether this should include patients with preserved ejection fraction is debatable. OBJECTIVE: The study aimed to investigate the variation in stroke risk of AF patients with heart failure with preserved ejection fraction (HFpEF), heart failure with mid-range ejection fraction (HFmrEF), and heart failure with reduced ejection fraction (HFrEF) for enhancing risk assessment and subsequent management strategies. METHODS: In a longitudinal study using the National Taiwan University Hospital integrated Medical Database, 8358 patients with AF were observed for 10 years (mean follow-up, 3.76 years). The study evaluated the risk of ischemic stroke in patients with differing ejection fractions and CHA2DS2-VASc score, further using Cox models adjusted for risk factors of AF-related stroke. RESULTS: Patients with HFpEF and HFmrEF had a higher mean CHA2DS2-VASc score compared with patients with HFrEF (4.30 ± 1.729 vs 4.15 ± 1.736 vs 3.73 ± 1.712; P < .001) and higher risk of stroke during follow-up (hazard ratio [HR], 1.40 [1.161-1.688; P < .001] for HFmrEF; HR, 1.184 [1.075-1.303; P = .001] for HFpEF vs no CHF) after multivariate adjustment). In patients with lower CHA2DS2-VASc score (0-4), presence of any type of CHF increased ischemic stroke risk (HFrEF HR, 1.568 [1.189-2.068; P = .001]; HFmrEF HR, 1.890 [1.372-2.603; P < .001]; HFpEF HR, 1.800 [1.526-2.123; P < .001] vs no CHF). CONCLUSION: After multivariate adjustment, HFpEF and HFmrEF showed a similar risk of stroke in AF patients. Therefore, it is important to extend the criteria for C in the CHA2DS2-VASc score to include patients with HFpEF and HFmrEF. In patients with fewer concomitant stroke risk factors, the presence of any subtype of CHF increases risk for ischemic stroke.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stroke VolumeHeart FailureAtrial FibrillationHumansMaleFemaleTaiwanAgedRisk AssessmentRisk FactorsLongitudinal StudiesFollow-Up StudiesMiddle AgedStrokeIncidenceVentricular Function, LeftRetrospective StudiesPrognosis

Stichwörter der Autor:innen

Atrial fibrillationCHA(2)DS(2)-VASc scoreHFmrEFHFpEFHFrEFIschemic stroke

Autor:innen und Institutionen

  • National Taiwan University College of Medicine, Taipei, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Tai…
  • Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan.
  • Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: cttsai1999@gmail.com.

Förderung

  • National Science and Technology Council

Zitieren

APA

Cheng, C. C., Huang, P. S., Chen, J. J., Chiu, F. C., Chang, S. N., Wang, Y. C., Wu, C. K., Hwang, J. J., & Tsai, C. T. (2024). Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2024.02.048

Vancouver

Cheng CC, Huang PS, Chen JJ, Chiu FC, Chang SN, Wang YC, et al. Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort. Heart Rhythm. 2024. doi:10.1016/j.hrthm.2024.02.048

BibTeX
@article{Cheng2024,
  author = {Cheng, Chien-Chien and Huang, Pang-Shuo and Chen, Jien-Jiun and Chiu, Fu-Chun and Chang, Sheng-Nan and Wang, Yi-Chih and Wu, Cho-Kai and Hwang, Juey-Jen and Tsai, Chia-Ti},
  title = {Both HFpEF and HFmrEF should be included in calculating CHA2DS2-VASc score: A Taiwanese longitudinal cohort},
  journal = {Heart Rhythm},
  year = {2024},
  doi = {10.1016/j.hrthm.2024.02.048}
}
Kostenlos starten →